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Background
Immunohistochemical studies suggest that the rheumatoid
nodule (RN) is a Th1 granuloma [1], with focal vasculitis
[2], yet the pathogenesis remains unclear and little is
known about circulating cytokines in these patients.
Objective
We measured circulating cytokines of DMARD-naïve early
RA patients, and compared profiles of patients with RN to
those without RN.
Methods
A cross-sectional cohort of 149 DMARD-naïve adults with
early RA (symptom duration ≤ 2 years). Assessments
included a smoking history, the presence of subcutaneous
RN, the Simplified Disease Activity Index (SDAI), and
X-rays scored using the modified Larsen method, Rheu-
matoid Factor (RF) and anti cyclic citrullinated peptides
(aCCP) tests. Serum cytokines were measured using the
Bio-Plex
® suspension array system. Differences between
patients with RN and those without RN were explored
using univariate and multivariate techniques, correcting
for SDAI by regression analysis.
Results
Of 149 patients (120 females), the majority were Black
Africans (93%) and 34 (22.8%) had RN. Patients with RN
were more likely to be males, but neither smoking history
nor symptom duration was significantly different between
the two groups. RN patients had severe RA with higher
SDAI (p=0.04) and X-ray scores (p=0.004), and higher RF
(p=0.005) and aCCP (p=0.04) titers. Cytokine profiles in
the RN patients showed significant elevation of predomi-
nantly Th1 cytokines, with higher interferon-gamma (IFN-
G) (p=0.05), interleukin (IL)-12 (p=0.02), and IL-2
(p=0.05). In addition, cytokines of macrophage (TNF-a,
p=0.16) and fibroblast origin( I L - 7 ,p = 0 . 0 5a n dv a s c u l a r
endothelial growth factor, p=0.03) were significantly higher
in these patients. Multivariate analysis showed IL-7
(p<0.001) and IFN-G (p=0.001) to be independently
significant.
Conclusion
DMARD-naïve early RA patients with RN have a unique
serum cytokine profile, with significant elevation of pre-
dominantly Th1 and fibroblast cytokines.
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